Feelemyer-276x303 photo
Jonathan Feelemyer, MS
NYU School of Global Public Health - Project Director
MS, Epidemiology, University at Albany School of Public Health
BA, Health and Society, University of Rochester
Research Interests
Injecting drug use, Epidemiology, HIV, HCV, Sexually transmitted diseases, Harm reduction, Research synthesis
Jonathan Feelemyer is a project director at the NYU School of Global Public Health.  His research interests include HIV, hepatitis C, sexually transmitted diseases, injection drug use, and harm reduction for at risk populations. His research is focused on international settings specifically in Southeast Asia and Eastern Europe. He has published numerous publications in academic journals and has presented his work at national and international conferences.  He has collaborated with researchers from New York University, Columbia University, the Centers for Disease Control and Prevention, and researchers in Estonia, Vietnam, Russia, France, and other countries.  He has worked collaboratively on numerous meta-analysis and systematic review studies, synthesizing research from multiple countries and time periods examining different research topics related to HIV and HCV.  He currently works with Dr. Don Des Jarlais on research projects addressing harm reduction, combined prevention, and reductions in HIV and HCV among different at risk populations, with special focus on high prevalence settings worldwide.


Rudolph KE, Kinnard EN, Aguirre AR, Goin DE, Feelemyer J, Fink D, Cerda M (2020).
The relative economy and drug overdose deaths
Epidemiology, 31 (4), 551-558. doi: 10.1097/EDE.0000000000001199.

Des Jarlais DC, Sypsa V, Feelemyer J, Abagiu AO, Arendt V, Broz D, Chemtob D, Seguin-Devaux C, Duwve JM, Fitzgerald M, Goldberg DJ, Hatzakis A, Jipa RE, Katchman E, Keenan E, Khan I, Konrad S, McAuley A, Skinner S, Wiessing L (2020).
HIV outbreaks among people who inject drugs in Europe, North America, and Israel
Lancet HIV, 7 (6), e434-e442. doi: 10.1016/S2352-3018(20)30082-5.

Arasteh K, Des Jarlais DC, Feelemyer J, McKnight C (2020).
Hepatitis C incidence and prevalence among Puerto Rican people who use drugs in New York City
Global Public Health [Epub 2020 May 19]. doi: 10.1080/17441692.2020.1768276.

Moles JP, Vallo R, Khue PM, Huong DT, Oanh KTH, Thoa NT, Giang HT, Thanh NTT, Vinh VH, Bui Thi TA, Peries M, Arasteh K, Quillet C, Feelemyer J, Michel L, Des Jarlais D, Laureillard D, Nagot N (2020).
HIV control programs reduce HIV incidence but not HCV incidence among people who inject drugs in HaiPhong, Vietnam
Scientific Reports, 10 (1), 6999. doi: 10.1038/s41598-020-63990-w. PMCID: PMC7181676.

Des Jarlais DC, Feelemyer J, LaKosky P, Szymanowski K, Arasteh K (2020).
Expansion of syringe service programs in the United States, 2015-2018
American Journal of Public Health, 110 (4), 517-519. doi: 10.2105/AJPH.2019.305515. PMCID: PMC7067090.


Feelemyer J, Des Jarlais D, Arasteh K, Abdul-Quader AS, Hagan H (2014).
Retention of participants in medication-assisted programs in low- and middle-income countries: An international systematic review
Addiction, 109 (1), 20-32. doi: 10.1111/add.12303. PMCID: PMC5312702.

Feelemyer J, Des Jarlais DC, Arasteh K, Phillips BW, Hagan H (2014).
Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: An international systematic review
Drug and Alcohol Dependence, 134, 251-258. doi: 10.1016/j.drugalcdep.2013.10.011. PMCID: PMC3880839.

Feelemyer J, Des Jarlais D, Arasteh K, Uuskula A (2015).
Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: An international systematic review
AIDS and Behavior, 19 (4), 575-583. doi: 10.1007/s10461-014-0928-3. PMCID: PMC4393761.

Jonathan Feelemyer's ResearchGate Profile